• The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain

  NCT01944163

  Unknown statusInterventionalNot ApplicableUpdated Nov 24, 2015
• Spondyloarthritis Inception Cohort of Southern Denmark

  NCT06337513

  Enrolling by invitationInterventionalNot ApplicableUpdated Sep 22, 2025
• Video Coaching of Physical Activity in Axial Spondyloarthritis

  NCT03965650

  Active, not recruitingInterventionalNot ApplicableUpdated Jul 16, 2026
• EXercise Therapy in Axial SpA, Inflammation and Biologic Therapy (ExTASI-B)

  NCT06669702

  RecruitingInterventionalNot ApplicableUpdated Nov 5, 2024
• Explore the Associations of Behavioral Factors With Treatment Adherence in Axial Spondyloarthritis Patients Treated With Biotherapy.

  NCT04925037

  Unknown statusObservationalUpdated Mar 4, 2022
• Microbiome and Axial Spondyloarthritis

  NCT04713995

  TerminatedInterventionalNot ApplicableUpdated Jul 8, 2022

ClinicalTrials.gov ID

NCT07141017

Lead Sponsor

Association de Recherche Clinique en RhumatologieOTHER

Overall Status

Recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

154Estimated

Last Update Posted

Aug 26, 2025Actual

Start Date

May 12, 2025Actual

Primary Completion Date

May 2027Estimated

Completion Date

May 2027Estimated

Official Title

Evaluating the Impact of an Initial Standardized Global Review in Patients With Early Axial Spondyloarthritis: a Multicenter Randomized Cluster-controlled Study

Brief Summary

This study will be a pragmatic, cluster-randomized, controlled study with two parallel arms ( 'intervention' and 'usual care' (UC) arms) of one year duration.

The study will be open-label, but centers randomized in the UC arm will not be aware of the intervention performed in the 'intervention' centers.

The primary objective of this study will be to determine whether participation in a standardized global review (that includes assessment of disease domains and education ) as soon as possible after diagnosis of axial spondyloarthritis has a beneficial impact on patient knowledge of the disease at 12 months. The primary endpoint will be the change in the SPAKE (SPondyloArthritis Knowledge Questionnaire) questionnaire between M0 and M12.

• Axial Spondylarthritis (axSpA)

• Initial standardized global review

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Adults (but age <80years) with a diagnosis of axial spondyloarthritis determined by the treating rheumatologist within the 12 months preceding the baseline visit, who have completed the informed consent and have the ability to complete all study activities.

Exclusion Criteria:

• Patients who have already received a specific (or plan to receive in the coming 12 months) and dedicated program/global evaluation including education on the disease or treatments.
• Patients with any physical or mental condition that may affect understanding of the intervention or adherence to treatment (e.g. major depression or substance/alcohol use - might have impact on the outcomes of interest in the study).

Primary Purpose

Other

Allocation

Randomized

Interventional Model

Parallel Assignment

Masking

None (Open Label)

Lead Sponsor

Association de Recherche Clinique en RhumatologieOTHER

Collaborators

RCTsINDUSTRY

dernis-e@chu-caen.fr